Symbols

NXTS

Nexentis·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About NXTS

Nexentis Technologies Inc.

An agricultural food technology company

Industry

Financial services

Established Date

04/01/2009

Listing Date

05/14/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

nexentistech.com

Security Type

Common stock

Office address

Pinhas Sapir St. 3 Kiryat HaMada Ness Ziona 7403626 Israel

Business

Introduction

Nexentis Technologies Inc., was incorporated in Delaware on April 1, 2009 and re-incorporated in Nevada on November 10, 2023. The company focuses on sustainable operations in solar projects and oncology biotechnology. Through its wholly-owned subsidiary MitoCareX Bio Ltd., it is a drug discovery company targeting the mitochondrial vector family for cancer and inflammatory metabolic diseases, while its Solterra business develops renewable energy projects in Europe.

Company Financials

EPS

NXTS has released its 2025 Q2 earnings. EPS was reported at -0.18, versus the expected 0, missing expectations. The chart below visualizes how NXTS has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

NXTS has released its 2025 Q4 earnings report, with revenue of -68.00K, reflecting a YoY change of 1.45%, and net profit of 1.24M, showing a YoY change of 187.81%. The Sankey diagram below clearly presents NXTS's revenue sources and cost distribution.